Study on Adherence to Glaucoma Medication Regimens

A recent study aimed to objectively measure adherence to glaucoma medication regimens using electronic monitoring. The study focused on two groups of patients: those using once-daily prostaglandin analogs as their sole ocular hypotensive therapy and those requiring an adjunctive medicine alongside the prostaglandin analog. The research involved 62 adult subjects diagnosed with open-angle glaucoma (OAG) or ocular hypertension, evenly divided between the two groups. An electronic event medication monitoring device was employed to record each instance of medication bottle opening, with the study's main outcome measures being dosing errors and the proportion of pharmacologic duration covered by dosing relative to the prescribed regimen. The findings indicated that adherence to the once-daily prostaglandin regimen was good across both groups by all measures.